2.Gastric adenocarcinoma presenting as a submucosal tumor: A case report
John Mark K. Torres ; Timothy Carl F. Uy ; Ruter M. Maralit
Acta Medica Philippina 2024;58(3):76-81
Gastric adenocarcinoma presenting as a submucosal tumor (SMT) accounts to only 0.1% to 0.63%. A 56-year-old Filipino male presenting with new onset melena underwent magnifying endoscopy, narrow-band imaging, endoscopic ultrasound, and computed tomography revealing a 2.5 cm x 2.0 cm polypoid SMT-like lesion at the fundus. Total gastrectomy with lymph node dissection and esophagojejunostomy was performed with histopathology showing adenocarcinoma. This suggests the need for different modalities to ensure the accuracy of diagnosis and the need for subsequent invasive treatments.
3.R-CHOP and consolidation radiotherapy for limited-stage and low-IPI high-grade b-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: A single-center case series and review of literature
Joseff Karl U. Fernandez ; Michael D. San Juan ; Edilberto Joaquin V. Fragante, Jr. ; Billionario Januario Antonio D. Veloso, Jr. ; Timothy Carl F. Uy ; Michelle Regina L. Castillo ; Benedict Mihangel P. Crisostomo
Acta Medica Philippina 2024;58(Early Access 2024):1-11
High-Grade B-Cell Lymphoma (HGBCL) with gene rearrangements in MYC and BCL2 and/or BCL6 is an aggressive malignancy usually presenting in advanced stages. Current recommendations suggest the use of regimens more intensive than R-CHOP (rituximab, cyclophosphamide, vincristine, doxorubicin, prednisone), which are based on retrospective studies and single-arm prospective trials that included patients who are mostly in the advanced stage, and did not receive consolidation radiotherapy.
The optimal approach and treatment of HGBCL, whether limited-stage (LS) or advanced-stage, remains to be
determined. Here we describe the promising outcomes of three patients with LS and low IPI HGBCL with the use of R-CHOP as induction chemotherapy regimen, which was followed by consolidation radiotherapy.
Three women, 54-, 60-, and 64-years of age diagnosed to have HGBCL with MYC, and BCL2 and/or BCL6 rearrangements, with Ann Arbor stages I-IIE were included in this case series. All three patients had complete metabolic response to 6 cycles of R-CHOP and was subsequently treated with consolidation involved site radiotherapy (ISRT; total dose 30-36 Gy). Chemotherapy and radiotherapy were tolerated very well. All patients remain to be in remission, with the longest being at 23 months.
Outcomes of patients with HGBCL generally remain to be poor, but this may not be the case for patients with
limited-stage disease and favorable clinicopathologic risk profile. Nevertheless, the treatment of HGBCL is currently evolving and more studies are needed to determine the ideal approach and preferred chemotherapy regimen. Also, more studies are needed to elucidate the potential role of consolidation radiotherapy in patients with limited-stage HGBCL to improve survival outcomes. Findings of this case series suggest that patients with LS HGBCL may still derive benefit from R-CHOP followed by consolidation ISRT, but prospective trials are needed to confirm this.
4.Knowledge, attitudes, and practices in colorectal cancer screening in the Philippines
Joseff Karl U. Fernandez ; Martin Augustine B. Borlongan ; Michael Anthony A. Baliton ; Dennis L. Sacdalan ; Florge Francis A. Sy ; Analigaya R. Agoncillo ; Carl Lawrence C. Arenos ; Vincent F. Tatoy ; Timothy Joseph S. Uy ; Isabela Andrea L. Reveldez ; Steven Johnson L. Lim
Acta Medica Philippina 2024;58(Early Access 2024):1-15
Background and Objective:
Colorectal cancer (CRC) has the third highest incidence in the Philippines. Currently,
there is a paucity in literature that is focused on the knowledge, attitudes, and perceptions of Filipinos regarding CRC screening. This is the first study in the Philippines that describes this.
Methods:
This is a cross-sectional study that validated a 52-item Filipino questionnaire on the knowledge on
colorectal cancer, willingness to undergo CRC screening, and perceived benefits and barriers to fecal occult blood test (FOBT) and colonoscopy. The study enrolled household heads more than 20 years of age residing in both urban and rural communities in the Philippines.
Results:
The UP-PGH CRC KAP (University of the Philippines – Philippine General Hospital Colorectal Cancer
Knowledge, Attitudes, and Practices) and Rawl Questionnaire’s validity and internal consistency were established in a pilot study of 30 respondents. A total of 288 respondents were then enrolled to the main study group with a median age of 54.0. Knowledge scores for prognosis and utility of CRC screening were modest (6.3/12 and 8.4/20, respectively). Perceived benefit scores to FOBT and colonoscopy were high (9.9/12 and 13.9/16, respectively).Median scores to barriers to FOBT and colonoscopy were intermediate (22.5/36 and 35.8/60, respectively). Notably, a vast majority (86.1%) were willing to participate in CRC screening programs initiated by the government, and 46.9% agreed to undergo screening tests even as out-of-pocket expense.
Conclusion
The UP-PGH CRC KAP Questionnaire as well as the Filipino translation of the Rawl Questionnaire
are reliable and valid tools in extensively assessing the knowledge of Filipinos on CRC and willingness to undergo screening, as well as the benefits of and barriers to FOBT and colonoscopy. Knowledge scores were modest suggesting that directed educational campaigns and awareness programs can aid in increasing awareness about CRC and its screening. Household income and highest educational attainment were significantly positively correlated with knowledge scores, and perceived benefits of and barriers to CRC screening. Scores were generally comparable between urban and rural communities.
Knowledge
;
Attitudes